Tag: AI biotech

GenBio launches stateful AIDO Cell to simulate whole human cells

GenBio AI launches AIDO Cell, a stateful virtual cell that predicts how DNA, RNA and proteins shape whole-cell behavior.

By

Robinhood Ventures Fund II brings retail capital to healthcare AI

Robinhood Ventures Fund II began trading on the New York Stock Exchange today under the ticker RVII, listing at $25.00…

By

Adialante brings accessible MRI-based cancer screening

Adialante is working to make MRI-based cancer screening accessible beyond major hospital centers.

By

CellType models biology so AI can discover drugs

CellType runs agentic drug discovery on simulated human biology, letting AI agents test hypotheses before wet-lab work begins.

By

Healthcare AI startups in Robinhood Ventures Fund II

Robinhood Ventures Fund II backs healthcare AI startups spanning simulated drug discovery, accessible imaging, and clinical operations.

By

AI-focused venture firm Dimension restocks with $800M third fund

AI-biotech venture firm Dimension closes $800M third fund to invest at the intersection of computing and life sciences.

By